Oncgnostics GmbH - Product Pipeline Analysis, 2018 Update

  • ID: 4267291
  • Company Profile
  • 23 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • BioNTech AG
  • biosyn Arzneimittel GmbH
  • BIOTECON Diagnostics GmbH
  • MORE
Oncgnostics GmbH (Oncgnostics) is an in-vitro diagnostic company that offers development of in-vitro diagnostic tests for the therapeutics area of cancer. The company’s pipeline products include GynTect technology a system based on the detection of epigenetic biomarkers mainly in the methylation of specific DNA regions. Its GynTect also allows a fast and reliable detection of cervical precancerous lesions and cancer. Oncgnostics’ pipeline focuses on applications in the fields that include ovarian cancer and head-and-neck tumors, among others. The company also provides IVD test development field after test validation and initial preclinical trials, and others. Oncgnostics is headquartered in Jena, Germany.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Oncgnostics GmbH
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • BioNTech AG
  • biosyn Arzneimittel GmbH
  • BIOTECON Diagnostics GmbH
  • MORE
  • Oncgnostics GmbH Company Overview
  • Oncgnostics GmbH Company Snapshot
  • Oncgnostics GmbH Pipeline Products and Ongoing Clinical Trials Overview
  • Oncgnostics GmbH - Pipeline Analysis Overview
  • Oncgnostics GmbH - Key Facts
  • Oncgnostics GmbH - Major Products and Services
  • Oncgnostics GmbH Pipeline Products by Development Stage
  • Oncgnostics GmbH Pipeline Products Overview
  • GynTect
  • GynTect Product Overview
  • GynTect 2.0
  • GynTect 2.0 Product Overview
  • Oncgnostics Diagnostic Test - Head & Neck Cancer
  • Oncgnostics Diagnostic Test - Head & Neck Cancer Product Overview
  • Oncgnostics Diagnostic Test - Ovarian Cancer
  • Oncgnostics Diagnostic Test - Ovarian Cancer Product Overview
  • Oncgnostics GmbH - Key Competitors
  • Oncgnostics GmbH - Key Employees
  • Oncgnostics GmbH - Locations And Subsidiaries
  • Head Office
  • Recent Developments
  • Oncgnostics GmbH, Recent Developments
  • Sep 20, 2016: Early Detection of Ervical cancer: “ GynTect 2.0“- Wider Range of Application by Using a Greater Variety of Patient Samples
  • Apr 28, 2016: Oncgnostics cooperates with SAYRE Therapeutics in India
  • Jan 20, 2016: Safe Diagnostics for Women Tested HPV-Positive
  • Sep 18, 2015: Fast and Reliable Results in Cancer Diagnostics: Biotech Startup Oncgnostics Receives CE Mark for Cervical Cancer Test GynTect
  • Nov 25, 2014: Oncgnostics Received Award At The Thuringian Innovation Prize 2014
  • Appendix
  • Methodology
List of Tables
  • Oncgnostics GmbH Pipeline Products and Ongoing Clinical Trials Overview
  • Oncgnostics GmbH Pipeline Products by Equipment Type
  • Oncgnostics GmbH Pipeline Products by Indication
  • Oncgnostics GmbH, Key Facts
  • Oncgnostics GmbH, Major Products and Services
  • Oncgnostics GmbH Number of Pipeline Products by Development Stage
  • Oncgnostics GmbH Pipeline Products Summary by Development Stage
  • GynTect - Product Status
  • GynTect - Product Description
  • GynTect 2.0 - Product Status
  • GynTect 2.0 - Product Description
  • Oncgnostics Diagnostic Test - Head & Neck Cancer - Product Status
  • Oncgnostics Diagnostic Test - Head & Neck Cancer - Product Description
  • Oncgnostics Diagnostic Test - Ovarian Cancer - Product Status
  • Oncgnostics Diagnostic Test - Ovarian Cancer - Product Description
  • Oncgnostics GmbH, Key Employees
  • Glossary
List of Figures
  • Oncgnostics GmbH Pipeline Products by Equipment Type
  • Oncgnostics GmbH Pipeline Products by Development Stage 8
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • BIOTECON Diagnostics GmbH
  • biosyn Arzneimittel GmbH
  • BioNTech AG
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll